Radioactive Fiducial Marker for Gamma Camera Lesion Localization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current imaging modalities for breast cancer, such as mammography, ultrasound, and MRI, face challenges in accurately identifying and localizing cancerous lesions, especially in dense breast tissue or when multiple lesions are present, leading to inaccuracies in biopsy guidance.

Innovation Solution

A novel fiducial marker for a gamma-guided stereotactic localization system that uses a radioactive source to provide accurate positioning and guidance for biopsy equipment, enabling precise imaging and targeting of cancerous lesions through gamma camera detection of metabolic activity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional imaging modalities (mammography, ultrasound, MRI) are used for lesion localization, then the imaging process is straightforward and equipment is readily available, but the accuracy of identifying and localizing cancerous lesions deteriorates, especially in dense breast tissue or when multiple lesions are present

Engineering Contradiction:
Improvelesion localization accuracyVSAvoidimaging system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent introduces a fiducial marker as an intermediary object that is implanted near the lesion and emits gamma rays. This marker serves as a mediator between the imaging system and the lesion, providing a known reference point that significantly improves localization accuracy. The gamma camera detects the fiducial marker's position with high precision, and this information is used to calculate the lesion's location relative to the marker, thereby resolving the contradiction between measurement precision and device complexity.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If mammography is used for imaging, then the procedure is simple and widely available, but the ability to identify cancerous lesions deteriorates when patients have dense breast tissue, multiple suspicious lesions, or other complicating factors

Engineering Contradiction:
Improvecancer lesion identification accuracyVSAvoidimaging procedure simplicity
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The fiducial marker acts as a reliable intermediary that emits detectable gamma rays, providing a consistent reference point that enhances the reliability of lesion identification. By detecting the marker's position and using it to calculate lesion location, the system overcomes the limitations of mammography in dense tissue and complex cases, thereby improving reliability while maintaining procedural simplicity.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the imaging parameter from detecting tissue density (mammography) or structural information (MRI, ultrasound) to detecting gamma ray emissions from the fiducial marker. This parameter change enables reliable lesion identification in cases where traditional modalities fail, such as dense breast tissue or multiple lesions, without significantly complicating the imaging procedure.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If biopsy guidance is performed without a fiducial marker, then the procedure is simpler, but the accuracy of positioning biopsy equipment at the target lesion deteriorates

Engineering Contradiction:
Improvebiopsy needle positioning accuracyVSAvoidpositioning system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The fiducial marker serves as a mediator in the biopsy guidance process, providing a known reference point that is detected by the gamma camera. The system uses the marker's position to calculate the precise location of the lesion and guide the biopsy needle. This intermediary approach significantly improves positioning accuracy while adding minimal complexity to the overall procedure, as the marker is implanted during the same surgical procedure.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enhances the accuracy of lesion localization and biopsy guidance by correlating the fiducial marker's location with the gamma camera images, allowing for precise placement of biopsy needles and improving sensitivity and specificity in identifying cancerous lesions compared to traditional imaging methods.

Implementation Method 1

The fiducial can be made radioactive such that it can be seen by the gamma camera

Methodology Applied
Scientific EffectRadioactive decay: Radioactive Decay

Implementation Method 2

A gamma guided stereotactic localization system with improved positioning system includes a gamma-emitting fiducial source that can be imaged by the stereo imaging system

Methodology Applied
Scientific EffectGamma radiation detection: Radiation

Data Source

PatentUS8489177B2Fiducial marker and method for gamma guided stereotactic localization
Publication Date: 2013.07.16 SMART BREAST CORP
  • US8489177B2 patent drawing
  • US8489177B2 patent drawing
  • US8489177B2 patent drawing

AI summary

A fiducial marker for use in a gamma-guided stereotactic localization system for imaging a suspected cancer and guiding a physician in the removal of tissue samples for biopsy. The fiducial marker includes a fiducial source that can be accurately located in a positioning system and used to correlate the location of the positioning system with the detector and therefore the region-of-interest. The fiducial can be made radioactive such that it can be seen by the gamma camera. The fiducial marker enables the accurate positioning of other hardware in proximity to the object to be viewed.